After getting FDA clearance for video game therapeutic, Akili faces next level: insurance coverage
Akili Interactive, a digital health company that got FDA clearance last year for its video game as treatment for ADHD, recently brought in $160 million in funding. It plans to use the funds to ramp up coverage of its flagship treatment and to develop digital treatments for other cognitive conditions.
Other Articles in this Edition
Can acetaminophen use during pregnancy increase the risk of ADHD and autism symptoms in children?
Teens who stop taking ADHD medication at adulthood more prone to health, social problems
Longitudinal associations between symptoms of ADHD and BMI from late childhood to early adulthood
After getting FDA clearance for video game therapeutic, Akili faces next level: insurance coverage